virubloc microgel spray nasale
multichem r&d - spray nasale - aqua, glycerin, peg-40 hydrogenated castor oil, hydroxypropyl methylcellulose, menthyl nicotinate ( nicomenthyl ), sodium benzoate, citric acid, sodium citrate - qo30199 - dispositivi nasofaringei
dasatinib accord
accord healthcare s.l.u. - dasatinib - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - agenti antineoplastici - dasatinib accord is indicated for the treatment of adult patients with:• ph+ acute lymphoblastic leukaemia (all) with resistance or intolerance to prior therapy. dasatinib accord is indicated for the treatment of paediatric patients with:• newly diagnosed ph+ all in combination with chemotherapy.
dasatinib accordpharma
accord healthcare s.l.u. - dasatinib - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - agenti antineoplastici - dasatinib accordpharma is indicated for the treatment of adult patients with: newly diagnosed philadelphia chromosome positive (ph+) chronic myelogenous leukaemia (cml) in the chronic phase. chronic, accelerated or blast phase cml with resistance or intolerance to prior therapy including imatinib. ph+ acute lymphoblastic leukaemia (all) and lymphoid blast cml with resistance or intolerance to prior therapy. dasatinib accordpharma is indicated for the treatment of paediatric patients with: newly diagnosed ph+ cml in chronic phase (ph+ cml-cp) or ph+ cml-cp resistant or intolerant to prior therapy including imatinib. newly diagnosed ph+ all in combination with chemotherapy.
dasatinib teva
teva b.v. - dasatinib - dasatinib
dasatinib zentiva
zentiva italia s.r.l. - dasatinib - dasatinib
dasatinib teva italia
teva b.v. - dasatinib - dasatinib
dasatinib krka
krka d.d. novo mesto - dasatinib - dasatinib
dasatinib mylan
mylan s.p.a. - dasatinib - dasatinib
dasatinib sandoz
sandoz s.p.a. - dasatinib - dasatinib
dasatinib eg
eg s.p.a. - dasatinib - dasatinib